Cardiovascular Systems, Inc. (CSII) News

Cardiovascular Systems, Inc. (CSII): $14.54

0.18 (+1.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter CSII News Items

CSII News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CSII News Highlights

  • CSII's 30 day story count now stands at 14.
  • Over the past 27 days, the trend for CSII's stories per day has been choppy and unclear. It has oscillated between 1 and 7.
  • The most mentioned tickers in articles about CSII are ST, CF and FORD.

Latest CSII News From Around the Web

Below are the latest news stories about Cardiovascular Systems Inc that investors may wish to consider to help them evaluate CSII as an investment opportunity.

Cardiovascular Systems, Innova Vascular team up for thrombectomy devices

Cardiovascular Systems (NASDAQ:CSII) has collaborated with Innova Vascular to develop a full line of novel thrombectomy devices. Thrombectomy is an interventional procedure performed to remove blood clots from arteries and veins. The company intends to acquire and commercialize novel thrombectomy devices from Innova targeting peripheral vascular disease, including deep vein thrombosis...

Seeking Alpha | February 23, 2022

Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices

ST. PAUL, Minn., February 23, 2022--Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices

Yahoo | February 23, 2022

Cardiovascular Systems' (CSII) Q2 Earnings Lag Estimates

Cardiovascular Systems (CSII) exhibits a robust performance by its worldwide coronary franchise despite challenging business climate.

Yahoo | February 4, 2022

Cardiovascular Systems GAAP EPS of -$0.23 misses by $0.09, revenue of $59.1M misses by $3.56M, cuts FY guidance

Cardiovascular Systems press release (NASDAQ:CSII): Q2 GAAP EPS of -$0.23 misses by $0.09. Revenue of $59.1M (-7.9% Y/Y) misses by $3.56M. For the fiscal year ending June 30, 2022, CSI anticipates: Revenue of $235 million to $245 million from prior guidance of $265 million to $285 million vs. $270.17M consensus. Gross profit...

Seeking Alpha | February 3, 2022

Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q2 2022 Results - Earnings Call Transcript

No summary available.

Seeking Alpha | February 3, 2022

Cardiovascular Systems, Inc. 2022 Q2 - Results - Earnings Call Presentation

No summary available.

Seeking Alpha | February 3, 2022

Cardiovascular Systems GAAP EPS of -$0.23 misses by $0.09, revenue of $59.1M misses by $3.56M, cuts FY fuidance

Cardiovascular Systems press release (CSII): Q2 GAAP EPS of -$0.23 misses by $0.09.Revenue of $59.1M (-7.9% Y/Y) misses by $3.56M.For the fiscal year ending June 30, 2022,

Seeking Alpha | February 3, 2022

Cardiovascular Systems (CSII) Q2 2022 Earnings Call Transcript

CSII earnings call for the period ending December 31, 2021.

The Motley Fool | February 3, 2022

Cardiovascular Systems (CSII) Reports Q2 Loss, Misses Revenue Estimates

Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -64.29% and 5.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 3, 2022

Cardiovascular Systems, Inc. Reports Fiscal 2022 Second Quarter Financial Results

ST. PAUL, Minn., February 03, 2022--CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2022 SECOND QUARTER FINANCIAL RESULTS

Yahoo | February 3, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5182 seconds.